A federal appeals court will hear oral arguments regarding Maine's prescription data law, which allows physicians to "opt-out" of commercially traded data pertaining to their prescribing habits.

DDMAC is being upgraded from a division to an office, an FDA official said yesterday.

Eisai got an FDA untitled letter for two Aricept TV ads that the agency said overstate the efficacy of the drug.

Merck will consolidate media duties on all of its brands, including the newly acquired Schering-Plough portfolio, after a review.

The Healthcare Businesswomen's Association named Pfizer Vaccines President Mark Swindell its 2010 Honorable Mentor.

FDA is reviewing new data and reports on the safety of GlaxoSmithKline's blockbuster diabetes drug Avandia, and will present findings at a public meeting this summer.

President Obama's proposed healthcare reform fix would close the Medicare Part D "doughnut hole," crack down on "pay-for-delay" deals on generics and hike fees on branded drugs.

Pollen.com, an allergy site for consumers, is getting revamped with new features for the upcoming allergy season

US Oncology announced the purchase of Cure Media Group today, a move signaling an increased focus on cancer patients. US Oncology is a practice management and drug distribution firm.

Social media marketers should make it easy for consumers to consider the source when products are being discussed, according to new disclosure guidelines from the Word of Mouth Marketing Association (WOMMA).